IGC
#4444
IGC Pharma, Inc. Common Stock
0.2 8 USD
0.00%
Market Price
Sector: Healthcare
Base: USD
Profit Currency: USD
Daily Range
Year Range
Daily Change
0.00%
Monthly Change
-3.45%
6 month change
-4.96%
Year Change
+9.29%
Previous Close
0.2 8
Open
0.2 8
Low
0.2 8
High
0.2 8
Volume
36
Financials
- Market Capitalization 28.95 M
- Employee 70
- Founded 2005
- CEO N/A
- Website www.igcinc.us
- Headquarter Maryland, United States
- FIGI BBG000NSSLY8
- Industry Biotechnology
Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Price to earnings ratio
-3.17
Price to sales ratio
17.16
Related tickers
| # | Name | Price | 24h % | 7d % | 1M % | 1Y % | Market Cap | Last 7 Days | |
|---|---|---|---|---|---|---|---|---|---|
| 4431 |  QNCX Quince Therapeutics, Inc. - Common Stock | 29.55 USD | +2.04% | -7.31% | -5.71% | +1746.88% | 30.05 M USD | ||
| 4442 |  ESLA Estrella Immunopharma, Inc. - Common Stock | 0.67 USD | 0.00% | +4.69% | -6.94% | -38.53% | 29.14 M USD | ||
| 4448 |  RNAZ TransCode Therapeutics, Inc. - Common Stock | 1.69 USD | 0.00% | -14.65% | -51.58% | -82.23% | 28.61 M USD | ||
| 4464 |  CVM Cel-Sci Corporation Common Stock | 1.50 USD | -1.32% | -10.18% | +0.67% | -70.87% | 26.38 M USD |
Frequently asked questions about IGC Pharma, Inc.
What is the IGC Pharma, Inc. stock price today?
The current price of IGC Pharma, Inc. (IGC) is 0.28. Over the past 24 hours, the stock has changed by 0.00%. Follow the IGC chart for real-time price dynamics.
What is the stock ticker of IGC Pharma, Inc.?
IGC Pharma, Inc. trades under the ticker IGC. Tickers can differ by exchange, so always check the exchange and instrument details before trading.
Is IGC Pharma, Inc. stock going up?
IGC has changed by -6.67% over the last week, -3.45% over the last month, and +9.29% over the last year. Review the chart to see whether the current move is part of a broader trend.
What is the market capitalization of IGC Pharma, Inc.?
IGC Pharma, Inc. currently has a market capitalization of 28.95 M. Market capitalization reflects the total market value of a company's outstanding shares and is commonly used to compare companies by size.
What were IGC Pharma, Inc. earnings last quarter?
Last quarter, IGC Pharma, Inc. reported earnings of -0.03 per share. Earnings per share is one of the key metrics investors use to evaluate a company's profitability and financial performance.
What was IGC Pharma, Inc. revenue for the last quarter?
IGC Pharma, Inc. reported quarterly revenue of 265 K. Revenue is one of the main indicators used to evaluate the company's business growth and operating scale.
What was IGC Pharma, Inc. net income for the last quarter?
IGC Pharma, Inc. reported net income of -2.94 M for the last quarter. The previous quarter showed -2.4 M, which means net income changed by -22.23%.
How many employees does IGC Pharma, Inc. have?
As of the latest available data, IGC Pharma, Inc. has 70 employees. Workforce size can provide additional context about the company's scale and operations.
What is IGC Pharma, Inc. EBITDA?
IGC Pharma, Inc. EBITDA is -2.74 M, and its EBITDA margin is -1 035.47%. EBITDA is commonly used to evaluate operating performance before interest, taxes, depreciation, and amortization.
How can I buy IGC Pharma, Inc. stock?
You can buy IGC Pharma, Inc. (IGC) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.
Should I invest in IGC Pharma, Inc. stock?
Investing in IGC Pharma, Inc. requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the IGC chart and related analysis on metatrader.com as part of your research.